SGRH GETS MAXIMUM PARTICIPANTS FOR JOINT INDIA-ISRAEL TRIALS FOR NEW COVID 19 TECHNOLOGIES.

SIR GANGA RAM HOSPITAL RESEARCHERS REPORT A POSSIBLE EARLY MARKER FOR DIAGNOSIS OF   NEW BORN SEPSIS

New Delhi

Sir Ganga Ram Hospital which was one of the six centres for Joint India-Israel trials for new Covid-19 technologies has managed to get maximum participants for the study . The recruitment target for the study was 10000 participants . Recruitment achieved was 10022 . Number of participants from SGRH were 3232 , which is the highest among all centers. Dr Ambuj Garg , Consultant , Medicine Consultant , SGRH is the Principal Investigator for this study.

A certificate of appreciation has been awarded to Sir Ganga Ram Hospital by OPEN SKIES in this regard.

Israel’s DRDD ,Ministry of Defense and India’s DRDO have collaborated and successfully collected thousands of samples from both the countries to effectively reach a diagnostic solution for COVID-19 testing.

Author: sarkarimirror